Translation of Research on Sarcopenia Into Clinical Practice

The debate whether sarcopenia is a clinically relevant condition or just a matter for research is not novel.1 As explained by Bauer in a recent editorial published in this journal,2 the interest for conducting research on sarcopenia has “extended far beyond the field of aging and geriatric medicine, as it has been established as a highly relevant prognostic biomarker for a wide array of diseases.” At the same time, it is normal for a clinician to question whether the inclusion of sarcopenia in the list of active conditions can make any difference for a complex geriatric patient and substantially influence the decision process.